drugset / Trial / NCT06463938

A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

NCT06463938

Recruiting 120 enrolled Dow University of Health Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).

Timeline

Start
2024-05-12
Primary completion
2024-08-10
Completion
2024-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject CPP-ACP Protein / enzyme biologic